Assessing the Economic Value of Cancer Prevention
- 369 Downloads
It is critically important to discuss and quantify the economic value of cancer prevention, so that resources can be properly allocated toward its activities. In cancer prevention, there ain’t such thing as a free lunch. Building from four fundamental questions, this chapter provides an overview of how its value can be defined and assessed. Common concepts, such as benefit-risk, cost-effectiveness, budget-impact, and QALY, are explained with examples from the literature.
KeywordsNeoplasms Economics Cost and cost analysis Patient preference Decision-making
- Kozma CM, Reeder CE, Schulz RM (1993) Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research. Clin Ther 15(6):1121–1132. discussion 1120Google Scholar
- Marshall DA, Johnson FR, Kulin NA, Ozdemir S, Walsh JM, Marshall JK, Van Bebber S, Phillips KA (2009) How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey. Health Econ 18(12):1420–1439CrossRefGoogle Scholar
- Stacey D, Legare F, Lewis K, Barry MJ, Bennett CL, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Thomson R, Trevena L (2017) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev (4):Cd001431Google Scholar